Cargando…
Melanocortin therapies to resolve fibroblast-mediated diseases
Stromal cells have emerged as central drivers in multiple and diverse diseases, and consequently, as potential new cellular targets for the development of novel therapeutic strategies. In this review we revise the main roles of fibroblasts, not only as structural cells but also as players and regula...
Autores principales: | Khodeneva, Natalya, Sugimoto, Michelle A., Davan-Wetton, Camilla S. A., Montero-Melendez, Trinidad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922712/ https://www.ncbi.nlm.nih.gov/pubmed/36793548 http://dx.doi.org/10.3389/fimmu.2022.1084394 |
Ejemplares similares
-
Editorial: Melanocortins and melanocortin receptors in the regulation of inflammation: mechanisms and novel therapeutic strategies
por: Rinne, Petteri, et al.
Publicado: (2023) -
Senescence under appraisal: hopes and challenges revisited
por: Davan-Wetton, Camilla S. A., et al.
Publicado: (2021) -
Melanocortin Receptors as Novel Effectors of Macrophage Responses in Inflammation
por: Patel, Hetal B., et al.
Publicado: (2011) -
Ligand Bias and Its Association With Pro-resolving Actions of Melanocortin Drugs
por: Patruno, Sara, et al.
Publicado: (2018) -
Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides
por: Ahmed, Tazeen J., et al.
Publicado: (2013)